Rinite alérgica na visão do paciente
Allergic rhinitis from a patient’s perspective
Cristine Secco Rosário; Margarita Murrieta-Aguttes; Nelson Augusto Rosário Filho
Resumo
Os sintomas nasais têm impacto na vida dos pacientes com rinite alérgica. A maioria das pessoas alérgicas relata impacto negativo dos sintomas de alergia no trabalho e no desempenho escolar. Dentre todos os sintomas de alergia, o mais incômodo é a obstrução nasal, embora outros sintomas também tenham impacto na qualidade de vida dos pacientes, especialmente no sono. Os anti-histamínicos orais e corticosteroides nasais são as medicações mais frequentemente utilizadas para o tratamento de rinite, seguidos por descongestionantes orais ou intranasais. Os pacientes alérgicos frequentemente compram medicações sem prescrição médica nas farmácias, e nem sempre estão satisfeitos com o tratamento que lhes é oferecido. Os médicos devem trabalhar mais na comunicação com os pacientes alérgicos para atender às suas necessidades, abordando medo de efeitos colaterais, preocupações quanto aos sintomas de alergia e como estes interferem na qualidade de vida. Desse modo, a educação do paciente baseada em melhor comunicação pode facilitar o controle da rinite alérgica.
Palavras-chave
Abstract
Nasal symptoms have an impact on the daily lives of patients with allergic rhinitis. Most allergic individuals report a negative impact of allergy symptoms on work and school performance. Among all allergy symptoms, the most bothersome is nasal congestion, although other symptoms also have an impact on patients' quality of life, especially on their sleep. Oral antihistamines and intranasal corticosteroids are the most frequently used medications for rhinitis, followed by oral or intranasal decongestants. Allergic patients frequently purchase different over-the-counter medications and sometimes are not satisfied with proposed treatments. Physicians should improve the communication with allergic patients to meet their needs, addressing fear of side effects, concerns about allergy symptoms and how they impact quality of life. Thus, educating patients through better communication may improve the control of allergic rhinitis.
Keywords
Referências
1. Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis. Treat Resp Med. 2005:4(6):439-46.
2. Church, MK, Máspero JF, Maurer M, Ryan D, Canonica GW, BaenaCagnani CE. The scope of pharmacological and clinical effects of modern antihistamines, with a special focus on rupatadine: Proceedings from a Satellite Symposium held at the 21st World Allergy Congress, Buenos Aires, 2009. World Allergy Organization Journal. 2010;3(Suppl 1):221.
3. IV Consenso Brasileiro sobre Rinites 2017. Braz J Otorhinolaryngol. 2018;84:1-44 F.
4. Meltzer EO, Blaiss MS, Naclerio RM, Stoloff SW, Derebery MJ, Nelson HS, et al. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. AllergyAsthma Proc. 2012;33(suppl 1):s113-s141.
5. Meltzer EO, Blaiss MS, Derebery MJ, Mahr TA, Gordon BR, Sheth KK, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol. 2009;124(suppl 1):S43‑S70.
6. Baena-Cagnani CE, Canonica GW, Zaky Helal M, Gómez RM, Compalati E, Zernotti ME, et al. The international survey on the management of allergic rhinitis by physicians and patients (ISMAR). World Allergy Organ J. 2015;8:10.
7. Fromer LM, Ortiz G, Ryan SF, Stoloff SW. Insights on allergic rhinitis from the patient perspective J Fam Pract. 2012;61(suppl2):s16‑s22.
8. Fromer LM, Blaiss MS, Jacob-Nara JA, Long RM, Mannion KM, Lauersen LA. Current allergic rhinitis experiences survey (CARES): Consumers' awareness, attitudes and practices. Allergy Asthma Proc. 2014:35:307-15.
9. Blaiss MS, Fromer LM, Jacob-Nara JA, Long RM, Mannion KM, LauersenLA. Current Allergic Rhinitis Experiences Survey (CARES): Health-care practitioners' awareness, attitudes and practices. Allergy Asthma Proc. 2014:35:316-22.
10. Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6:47.
11. Bousquet J, Bachert C, Canonica GW, Casale TB, Cruz AA, Lockey RJ, et al. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol. 2009;124:428-33.
12. Riedi CA, Westphal GGLC, Rosario NA, Santos HLBS,Takizawa K, Souza RVS, et al. Allergic conjunctivitis, rhinitis and asthma: one disease? J Allergy Clin Immunol. 2009;123(2):S261.
13. Marple BF, Fornadley JA, Patel AA, Fineman SM, Fromer L, Krouse JH, et al. Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction. Otolaryngol Head Neck Surg. 2007;136(suppl 6):S107-S124.
Submetido em:
10/02/2019
Aceito em:
17/02/2019
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email